Searched for
CANCER DRUG PRICE CAP
Apollo, Max Health, other hospital stocks rally up to 5% despite cancer drug price caps. Why Jefferies stays bullishHospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...- Cancer drugs may get up to 70% cheaper as govt fixes trade margins on non-scheduled medicines at 30%The government is aiming to cap trade margins on anti-cancer medications at 30%. An expert committee has been tasked with compiling a repor...
- Form panel to curb pharma freebies: SCThe Supreme Court has ordered the government to establish a committee to investigate unethical pharmaceutical marketing. The committee is t...
- National Medical Commission bans doctors & hospitals from using AI-generated patient testimonials, fake cure claims in medical adsThe National Medical Commission has implemented new ethical advertising guidelines affecting doctors and hospitals. These guidelines prohib...
- Govt set to cap trade margins on more cancer drugs before SC hearingThe Indian government plans to announce a new list of cancer drugs for trade margin rationalisation today. Union Health Minister JP Nadda w...
- Supreme Court seeks committee to curb pharma firms’ unethical marketing practicesThe Supreme Court has directed the government to form a committee regarding pharmaceutical marketing regulations. This follows concerns ove...
- Hospital pricing part of wider value chain: Max MDAbhay Soi, chairman of Max Healthcare, commented on scrutiny regarding hospital pricing in India. He stated that hospitals should be evalua...
- British Indian pair, accused of cancer drug fraud, fight extradition to USA British Indian businessman and his ex-wife are fighting extradition to the US over allegations that they defrauded Medicare and other hea...
- ‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEOEli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...
- Karnataka flags 52x mark-up on cancer drugs, seeks Centre's interventionKarnataka conducted inspections revealing significant price disparities between hospital procurement and patient billing for cancer drugs a...
- Fortis, Apollo, other hospital stocks slump up to 10% in 2 days after SC questions steep markups. Buying opportunity?Hospital stocks extended losses for a second session after the Supreme Court questioned steep markups on cancer drugs and raised concerns o...
- Jefferies picks 6 hospitals as Buy after steep correction offers 'excellent' entry points. Check target priceJefferies has maintained a Buy rating on six hospital stocks, including Apollo Hospitals and Fortis Healthcare, following a sharp correctio...
- Hospital stocks slip after SC query on steep cancer drug markupsIn a landmark ruling, the Supreme Court of India highlighted troubling markups on cancer drugs enforced by hospitals, urging a probe into r...
- Hospital stocks fall up to 6%: Apollo, Fortis, KIMS tumble as SC questions drug mark-upsHospital stocks came under pressure after the Supreme Court raised concerns over steep mark-ups on medicines sold through corporate hospita...
- SC seeks 16% MRP cap on medicines, flags huge cancer drug markupsThe Supreme Court has raised concerns regarding inflated prices of essential medicines, particularly cancer drugs, sold at exorbitant marku...
- Why is Summit Therapeutics share price up today by 22%?Summit Therapeutics share price is up today by 22% after biopharma firm announced AstraZeneca would invest $2 billion in it. British drugma...
- Cancer drug costs Rs 2,700, sells for Rs 27,000: SC questions 10x markup at hospitalsThe Supreme Court has questioned steep markups on cancer drugs and asked the Centre to examine a uniform 16% margin on all medicines. The c...
- Kerala HC says exorbitant drug prices can trigger government intervention in patented medicinesThe Kerala High Court ruled that government intervention is permissible for prohibitively priced patented medicines. The court directed the...
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
- 'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gapSupreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a...
Load More
